ReviewProtein & cell2026
Next-generation skin wound healing related disease models with integration of immune cells.
Review in Protein & cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Skin innervation and itsFrontiers in cellular neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Impaired wound healing and pathological scarring remain major clinical challenges, with immune cell dysregulation being a key driver of disease progression. Conventional in vitro models fail to recapitulate human immune responses, limiting their translational relevance. In recent years, advances in tissue engineering and microfluidic technologies have driven growing efforts to incorporate immune cells into in vitro models, thereby improving their ability to mimic pathological microenvironments. Among these, organ-on-a-chip technology stands out for its capacity to replicate dynamic perfusion, mechanical stimulation, and multicellular crosstalk-features critical for modeling immune-mediated wound repair. This review systematically summarizes recent progress in immune cell-integrated models of aberrant wound healing, including two-dimensional co-cultures, three-dimensional static cultures, organoid systems, and organ-on-a-chip platforms. We highlight core strategies for immune cell integration and their roles in recapitulating key pathological processes such as inflammation and fibrosis. Despite ongoing challenges in cell source stability, model standardization, and long-term culture viability, emerging strategies (e.g., organ-on-a-chip combined with three-dimensional bioprinting or modular design) offer new opportunities for creating biomimetic, high-throughput platforms for wound research. This review aims to facilitate the adoption of immune-integrated in vitro models in wound healing research, deepen mechanistic understanding of immune-driven pathology, and accelerate the development of precision therapeutics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.